HPV Vaccine Gardasil Approved For Sale In European Union

Main Category: Cancer / Oncology
Also Included In: Women's Health / Gynecology;  Cervical Cancer / HPV Vaccine
Article Date: 27 Sep 2006 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 and a half stars

3.5 (2 votes)

Healthcare Prof:4 stars

4 (1 votes)


The European Commission on Friday approved Merck's human papillomavirus vaccine Gardasil for sale and marketing in the European Union, London's Guardian reports (Batty, Guardian, 9/22). FDA in July approved Gardasil for sale and marketing to girls and women ages nine to 26. According to Merck, the vaccine -- which is given in three injections over six months and costs $360 -- in clinical trials has been shown to be 100% effective in preventing HPV infection with strains 16 and 18, which together cause about 70% of cervical cancer cases, in women who do not already have the virus, and about 99% effective in preventing HPV strains 6 and 11, which together with strains 16 and 18 cause about 90% of genital wart cases. Gardasil also protects against vaginal and vulvar cancers, two other gynecological cancers that are linked to HPV, according to a study presented in June at a meeting of the American Society of Clinical Oncology in Atlanta (Kaiser Daily Women's Health Policy Report, 9/22). Gardasil will be sold in the E.U. by Sanofi Pasteur, a joint company of Merck and Sanofi-Aventis. Sanofi Pasteur President Didier Hoch said the company will begin selling the drug in a European country by the end of next month (Reuters, 9/22). In the United Kingdom, the Joint Committee on Vaccination and Immunisation, an independent advisory committee for the U.K. Department of Health, will decide if the vaccine will be covered by the National Health System (Daily Mail, 9/22). A U.K. heath department spokesperson said the JCVI later this year will have meetings to review the vaccine's safety, efficacy and benefits, adding, "No decisions will be taken until the main JVCI present their recommendations to ministers for consideration" (BBC News, 9/22).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Gardasil.


Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Barbara Martin. "HPV Vaccine Gardasil Approved For Sale In European Union." Medical News Today. MediLexicon, Intl., 27 Sep. 2006. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/52651.php>

APA
Barbara Martin. (2006, September 27). "HPV Vaccine Gardasil Approved For Sale In European Union." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/52651.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »